SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AXS is the governance token for the Axie Infinity game. Token holders will be able to shape and vote for the direction of the game universe. This is unlike traditional games where all decisions are made by the game developers. AXS holders will be able to stake their tokens to earn more AXS and even vote for governance proposals.

Axie Infinity

Axie Infinity (AXS) is trending as the community anticipates significant upside potential driven by recent developments, including its integration with Apple Vision Pro, the launch of its V4 engine, and ongoing ecosystem enhancements on the Ronin network. Discussions highlight these strategic advancements and the platform's evolving role within the broader Web3 gaming and AI sectors.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network ($REACT) is drawing considerable attention, trending following its pivotal role as the first project on Ethereum's new EIL testnet, which aims to unify L2 chains and enable instant cross-chain automation. The community highlights its innovative "Smart Contracts 2.0" as a core infrastructure play, with growing excitement over recent integrations, increasing holder count, and the impending end of PRQ arbitrage. Many view $REACT as a resilient and severely undervalued asset, primed for significant exposure and adoption in the evolving crypto landscape.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals (SPRY) is trending following news of a competitor's FDA application deficiency, which is bolstering confidence in Neffy's market leadership as the first needle-free epinephrine option. The community is actively discussing a potential short squeeze, citing significant short interest and recent global regulatory approvals, alongside the company's expansion into new treatment areas like hives.

Wishing Well

WISH CRYPTO is gaining significant attention as its community eagerly anticipates key platform updates and chart activation, alongside ongoing contests designed to attract new long-term holders. Discussions highlight its unique deflationary tokenomics on the Solana blockchain, featuring monthly token burns tied to US inflation rates, which proponents believe will reward patient investors and distinguish it from other memecoins.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending amidst multiple analyst downgrades and intensified concerns over AI competition, including a new creative suite from Apple. The community is sharply divided, with some fearing AI will disrupt Adobe's core business, while others view its strong fundamentals and integrated AI features as a generational buying opportunity during this broader software sector downturn.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is experiencing a surge in attention following significant analyst upgrades from firms like Goldman Sachs and UBS, coupled with the announcement of Europe's largest 1 GW/4 GWh battery energy storage system. The community is highly optimistic, discussing the stock's potential for further upside, fueled by its robust project pipeline, record backlog, and pivotal role in addressing the escalating energy demands of AI data centers and grid stability challenges. This strong bullish sentiment is reinforced by Fluence's strategic focus on US manufacturing amid a booming energy storage sector.

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sutro Biopharma Inc

Sutro Biopharma is trending following a significant strategic shift to de-prioritize its lead asset, Luvelta, coupled with a major workforce reduction and a CEO transition, which has fueled widespread investor frustration and a sharp stock decline. The community is actively debating the company's future, weighing potential non-dilutive partnerships for Luvelta and the value of its proprietary ADC technology against ongoing concerns about cash burn and dilution risks.

The TJX Cos., Inc. engages in the retail of apparel and home fashion products. It operates through the following business segments: Marmaxx, HomeGoods, TJX Canada, and TJX International. The Marmaxx segment sells family apparel including apparel, home fashions, and other merchandise. The HomeGoods segment offers an assortment of home fashions, including furniture, rugs, lighting, soft home, decorative accessories, tabletop and cookware as well as expanded pet, kids, and gourmet food departments. The TJX Canada segment operates the Winners, Marshalls, and HomeSense chains in Canada. The TJX International segment includes operations of T.K. Maxx and Homesense chains in Europe and the T.K. Maxx chain in Australia. The company was founded by Bernard Cammarata in 1962 and is headquartered in Framingham, MA.

TJX Companies, Inc.

TJX Companies is trending due to robust earnings, an impressive holiday outlook, and optimistic analyst upgrades, reinforcing its strength in the retail sector. The community is actively discussing packed stores and how its off-price model is thriving amid consumers' value-seeking behavior, consistently outperforming competitors. This positive momentum highlights its resilient business model and global expansion potential.

Based Chad

The "Based Chad" memecoin is rapidly trending, fueled by significant engagement from Coinbase executives and its deep integration within the Base ecosystem, including official promotion. Its dedicated community highlights unique buyback mechanisms and consistent outperformance, with ongoing discussions around upcoming video games and potential airdrops that could drive further growth.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as its Etherlink L2 recently gained recognition for a "Uranium Tokenization Breakthrough" and staking accessibility expanded across major platforms. The community is actively debating XTZ's potential for Real World Asset (RWA) integration and its role in an anticipated altcoin season, with sentiment sharply divided between bullish predictions and skepticism over its tokenomics and utility. Broader discussions around crypto adoption and market liquidity further contribute to its elevated conversation volume.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc.

QRG Capital Management Inc. reduced its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 24.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The...

Gilead Sciences (NASDAQ:GILD) Insider Sells $372,930.00 in Stock

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) insider Johanna Mercier sold 3,000 shares of the company's stock in a transaction that occurred on Thursday, January 15th. The shares were sold...

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares of Stock

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) insider Johanna Mercier sold 3,000 shares of the company's stock in a transaction dated Thursday, January 15th. The stock was sold at an average...

Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) CFO Andrew Dickinson sold 3,000 shares of the company's stock in a transaction dated Thursday, January 15th. The shares were sold at an average...

Looking Into Gilead Sciences Inc's Recent Short Interest

Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 10.7% during the third quarter, according to the company in its most recent filing...

Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc.

Conning Inc. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 8.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 291,475 shares of the...

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Gilead Sciences (GILD) closed at $122.59, indicating a +1.23% shift from the previous trading day.

Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history

Daniel O'Day, Gilead Sciences CEO and chairman, joins 'Squawk Box' to discuss the advances in medicine, what to expect at the JPMorgan Healthcare Conference today, the company's Yeztugo HIV...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

GILD
Gilead Sciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GILD News

GILDGilead Sciences, Inc.